Related Experiment Video
Updated: May 22, 2026

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
Published on: August 24, 2019
Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010
Lisa J Herrinton1, Liyan Liu, Theodore R Levin
1Kaiser Permanente Northern California, Oakland, CA, USA. Lisa.herrinton@kp.org
Individuals with inflammatory bowel disease (IBD) have a 60% higher incidence of colorectal cancer (CRC) compared to the general population. This increased risk for CRC remained stable over time during the study period.
Area of Science:
- Gastroenterology
- Oncology
- Epidemiology
Background:
- The recent relationship between inflammatory bowel disease (IBD) and colorectal adenocarcinoma (CRC) incidence and mortality requires updated evaluation.
- IBD encompasses Crohn's disease (CD) and ulcerative colitis (UC), both chronic inflammatory conditions affecting the gastrointestinal tract.
Purpose of the Study:
- To evaluate the incidence and mortality rates of CRC in patients with IBD.
- To assess trends in CRC incidence and mortality in IBD patients compared to the general population.
- To examine changes in medication use and cancer detection rates over time within the IBD population.
Main Methods:
- Utilized Kaiser Permanente of Northern California data from 1998 to 2010 for members with IBD and the general population.
- Calculated incidence and standardized incidence and mortality rate ratios for CRC in adult individuals with intact colons.
- Analyzed trends in anti-tumor necrosis factor (anti-TNF) agent use and colonoscopy rates.
Main Results:
- Identified 29 CRC cases in Crohn's disease (CD) patients and 53 in ulcerative colitis (UC) patients.
- CRC incidence was 60% higher in IBD patients (CD and UC) compared to the general population (rate ratio: 1.6; 95% CI, 1.3-2.0).
- CRC incidence remained stable over time in IBD patients (CD P=.98, UC P=.40), contrasting with a 21% increase in the general population.
Conclusions:
- From 1998 to 2010, CRC incidence in IBD patients was consistently 60% higher than in the general population.
- The incidence of CRC in IBD patients remained stable throughout the study period.
- Standardized mortality ratios for CRC were elevated in both CD (2.3) and UC (2.0) patients.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease II: Ulcerative Colitis

